Viatris sets long-term financial targets, expects 5-6% revenue CAGR, $3 bln in annual free cash flow by 2030.

Viatris expects 5-6% revenue CAGR, 7-8% EBITDA CAGR, and 9-10% EPS CAGR through 2030. The company aims for over $3 bln in annual free cash flow in 2030 and has over $11 bln in cash available for deployment. The base case targets include 3-4% revenue CAGR, 4-5% EBITDA CAGR, and 6-7% EPS CAGR. Potential additional drivers include accretive business development and launches of selatogrel and cenerimod.